EN
中文 EN
Newsroom
Company News
Media Report
Company News
More
2026-08-28
CanSinoBIO Expands Innovative Product Portfolio as Internationalization Enters a New Phase — CEO Dr. Xuefeng Yu Speaks with Bloomberg TV
World Polio Day | CanSinoBIO Joins WHO Global Polio Vaccine Consultation for Third Consecutive Year
2026-10-24
CanSinoBIO Holds 2026 Scientific Advisory Board Meeting in Belgium
2026-10-16
CanSinoBIO Shares Perspectives on Innovation, Vaccine R&D and Accessibility at 2026 Sustainable Development Impact Meetings
2026-09-26
CanSinoBIO Shares Perspectives on the Future of Vaccine Manufacturing at 27th DCVMN Annual General Meeting
2026-09-23
CanSinoBIO and deepGeneAI Explore Collaboration in Personalized mRNA Cancer Vaccines
2026-08-25
Media Report
More
CanSinoBIO Reports Growth in First Nine Months: Commercialization Accelerates Across Multiple Products as Platform Innovation Opens New Avenues for Growth
Time：2026-10-27
More
[YiCai GLOBAL] Connecting Innovation and Global Markets: Jeanne Wang on CanSinoBIO’s Next Stage of Growth
Time：2026-09-24
More
Revenue Soars with 137% Year-on-Year Growth, Multiple Products Poised for Launch, CanSinoBIO's Growth Momentum Strong
Time：2025-03-28
More